Please try another search
Nipro Corporation, together with its subsidiaries, engages in the medical devices, pharmaceuticals, and pharma packaging businesses. Its Medical Device business develops, manufactures, and sells medical equipment for injection-infusion and dialysis treatment, and products related to diabetes and cell cultures, as well as the sale of artificial organ-related products. The company’s Pharmaceutical business provides pharmaceutical combination products, including dual chamber bags, pre-filled syringes, and half-type kits; and contract manufacturing services for orally administered drugs, injectables, and external preparations, as well as logistic and distribution services. Its Pharma Packaging business offers glass products and other comprehensive pharmaceutical packaging, such as glass vials, ampoules, and syringes; tube glass; and other parts of pharmaceutical packaging, such as rubber plugs, as well as provides glass for thermos bottles, and lighting and containers. The company also offers business management services. It serves customers in Japan, the Americas, Europe, and rest of Asia. The company was founded in 1947 and is headquartered in Osaka, Japan.
Name | Age | Since | Title |
---|---|---|---|
Kenichi Nishida | 54 | 2012 | Pharmaceutical Development Promotion Manager of Pharmaceutical Business Department, MD & Director |
Kawazu Hidehiko | - | 2022 | Independent Outside Director |
Hideto Nakamura | 66 | 2009 | GM of General Affairs & Human Resources, Manager of Personnel Dept and Director |
Kyoetsu Kobayashi | 69 | 2014 | MD, Manager of Production Business Department, Manager of Odate Plant & Director |
Yasushi Oyama | 62 | 2015 | MD, Manager of Vascular Business Department & Director |
Kazuhiko Sano | 72 | 2010 | Chief of Production Technology Center, Assistant Manager of Production Business Dept, MD & Director |
Shimamori Yoshiko | 77 | - | Independent Outside Director |
Yoshiko Tanaka | 75 | 2014 | Independent Outside Director |
Yoshitaka Akikuni | 71 | 2023 | Outside Statutory Auditor |
Shigeru Yanagase | 77 | 2023 | Outside Statutory Auditor |
Kiyotaka Yoshioka | 71 | 2006 | Chief of Business Strategy Office, MD, Manager of Domestic Business Dept and Director |
Toshiaki Masuda | 68 | 2015 | Chief of General Research Office, MD, Mngr of Planning Dev Technology Business Dept & Director |
Tsuyoshi Yamazaki | 56 | 2015 | Chief of Global Strategy Office, Manager of the MP Glass Business Department, Senior MD & Director |
Kimihito Minoura | 52 | 2009 | MD & Director |
Hidehiko Kawazu | 79 | 2022 | Independent Outside Director |
Hashimoto Katsunobu | 74 | 2022 | Independent Outside Director |
Yoshihiko Sano | 79 | 1993 | President & Representative Director |
Toyoshi Yoshida | 61 | 2010 | Manager of Quality Assurance & Regulatory Compliance Headquarters and Director |
Hattori Toshiaki | 70 | 2022 | Independent Outside Director |
Aoyama Kiyomi | 76 | 2022 | Independent Outside Director |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review